CRISPR Therapeutics AG【CRSP】 業績推移・財務諸表

(単位:千ドル) 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 1,549 2,344 2,703 3,582 2,387 32,325 1,358 1,088 563 115 328 318 211,928 77,016 157 44 148 370 539 900,701 824 940 158 94 100,000 70,000 - 504 517 602 865
売上成長率(%) - - - - - -
研究開発費 12,052 - 14,805 17,120 17,845 - 19,519 25,633 39,820 - 33,822 39,533 57,246 - 54,193 59,380 71,008 - 90,565 108,277 105,321 118,245 123,223 116,622 99,935 101,555 90,698 76,172 80,165 82,160 72,484
営業費用 16,159 27,654 23,447 24,888 25,957 31,353 28,355 38,374 49,995 45,343 48,751 55,301 72,765 66,033 73,743 80,733 92,547 108,131 115,082 138,083 129,673 176,912 183,418 182,482 164,487 165,223 132,411 141,091 151,777 110,732 149,289
営業利益 -14,610 -25,310 -20,744 -21,306 -23,570 972 -26,997 -37,286 -49,432 -45,228 -48,423 -54,983 139,163 10,983 -73,586 -80,689 -92,399 -107,761 -114,543 762,618 -128,849 -175,972 -183,260 -182,388 -64,487 -95,223 -132,411 -140,587 -151,260 -110,130 -148,424
営業利益率 (%) -
経常(税引前)利益 -14,686 - -21,196 -21,972 -24,000 - -28,214 -38,284 -50,574 - -48,323 -53,614 138,697 - -69,354 -79,277 -92,239 - -112,588 763,368 -127,748 -175,609 -179,716 -175,124 -51,745 -76,817 -111,740 -115,867 -125,121 -85,066 -134,887
経常(税引前)利益率(%) -948.1 - -784.17 -613.4 -1005.45 - -2077.61 -3518.75 -8982.95 - -14732.62 -16859.75 65.45 - -44174.52 -180175 -62323.65 - -20888.31 84.75 -15503.4 -18681.81 -113744.3 -186302.13 -51.75 -109.74 - -22989.48 -24201.35 -14130.56 -15593.87
法人税等合計 8 - 279 343 707 - 86 96 137 - 85 100 300 - 400 400 200 - 600 4,100 -600 3,600 6,100 -600 1,300 900 400 700 1,300 900 1,100
実効税率(%) - - - - -
純利益 -14,680 17,099 -21,475 -22,315 -24,707 140 -28,300 -38,380 -50,711 -47,590 -48,408 -53,699 138,423 30,542 -69,731 -79,656 -92,439 -107,039 -113,163 759,225 -127,153 -179,217 -185,834 -174,549 -53,065 -77,740 -112,152 -116,591 -126,408 -85,942 -135,996
純利益率(%) -
一株あたり利益 - - - - - - - - - - - - 2.52 0.53 - - -1.32 -1.5 -1.51 10.01 -1.67 -2.32 -2.4 -2.24 -0.67 -0.98 -1.41 -1.43 -1.49 -1.01 -1.58
希薄化後一株あたり利益 - - - - - - - - - - - - 2.4 0.51 - - -1.32 -1.5 -1.51 9.44 -1.67 -2.32 -2.4 -2.24 -0.67 -0.98 -1.41 -1.43 -1.49 -1.01 -1.58
EBITDA - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - -